262 related articles for article (PubMed ID: 22940257)
1. The classification of MDS: from FAB to WHO and beyond.
Vardiman J
Leuk Res; 2012 Dec; 36(12):1453-8. PubMed ID: 22940257
[TBL] [Abstract][Full Text] [Related]
2. A comparative review of classification systems in myelodysplastic syndromes (MDS).
Bennett JM
Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
[TBL] [Abstract][Full Text] [Related]
3. Detection of risk groups in myelodysplastic syndromes. A multicenter study.
Belli C; Acevedo S; Bengio R; Arrossagaray G; Watman N; Rossi N; García J; Flores G; Goldztein S; Larripa I
Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460
[TBL] [Abstract][Full Text] [Related]
4. The clinical implications of the World Health Organization's classification of myelodysplastic syndromes.
Komrokji RS; Bennett JM
Curr Hematol Rep; 2005 May; 4(3):175-81. PubMed ID: 15865868
[TBL] [Abstract][Full Text] [Related]
5. [Myelodysplastic syndromes: preleukemic syndromes].
Tassin F; Hermanne JP; Schaaf-Lafontaine N; Herens C; Thiry A; Paulus JM; Boniver J; Fillet G
Rev Med Liege; 1998 Jun; 53(6):357-62. PubMed ID: 9713217
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndromes classification and risk stratification.
Komrokji RS; Zhang L; Bennett JM
Hematol Oncol Clin North Am; 2010 Apr; 24(2):443-57. PubMed ID: 20359636
[TBL] [Abstract][Full Text] [Related]
7. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.
Bernasconi P; Klersy C; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Caresana M; Dambruoso I; Lazzarino M; Bernasconi C
Br J Haematol; 2007 May; 137(3):193-205. PubMed ID: 17408458
[TBL] [Abstract][Full Text] [Related]
8. The implications of revised WHO classification (2008) of chronic myeloid neoplasms.
Găman M; Vlădăreanu AM; Radesi S
Rom J Intern Med; 2011; 49(1):25-30. PubMed ID: 22026249
[TBL] [Abstract][Full Text] [Related]
9. Overview of myelodysplastic syndromes.
Beris P; Georgiou G
Semin Hematol; 2012 Oct; 49(4):287-94. PubMed ID: 23079058
[TBL] [Abstract][Full Text] [Related]
10. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F
Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic characteristics of patients with signs and symptoms of myelodysplastic syndromes in the State of Pará, Brazil.
Pinto GR; Overal DJ; Moraes LS; Van Den Berg AV; Lemos JA; Smith Mde A; Burbano RR
Genet Mol Res; 2005 Mar; 4(1):18-30. PubMed ID: 15841432
[TBL] [Abstract][Full Text] [Related]
12. Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification.
Font P; Loscertales J; Benavente C; Bermejo A; Callejas M; Garcia-Alonso L; Garcia-Marcilla A; Gil S; Lopez-Rubio M; Martin E; Muñoz C; Ricard P; Soto C; Balsalobre P; Villegas A
Ann Hematol; 2013 Jan; 92(1):19-24. PubMed ID: 22948274
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System.
van Spronsen MF; Ossenkoppele GJ; Westers TM; van de Loosdrecht AA
Eur J Cancer; 2016 Mar; 56():10-20. PubMed ID: 26798967
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis, classification, and course of myelodysplastic syndromes.
McKenna RW; Allison PM
Clin Lab Med; 1990 Dec; 10(4):683-706. PubMed ID: 2272170
[TBL] [Abstract][Full Text] [Related]
15. Clinical, haematological and histomorphological profile of adult myelodysplastic syndrome. Study of 96 cases in a single institute.
Chatterjee T; Dixit A; Mohapatra M; Tyagi S; Gupta PK; Mishra P; Bhattacharya M; Karan AS; Pati HP; Saxena R; Choudhry VP
Eur J Haematol; 2004 Aug; 73(2):93-7. PubMed ID: 15245507
[TBL] [Abstract][Full Text] [Related]
16. [Karyotypic and IPSS grouping of primary myelodysplastic syndromes patients: a comparison between FAB- and WHO-classification].
Yu MH; Liu SH; Shao YQ; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):482-5. PubMed ID: 15555265
[TBL] [Abstract][Full Text] [Related]
17. The myelodysplastic syndromes: classification and prognosis.
Komrokji R; Bennett JM
Curr Hematol Rep; 2003 May; 2(3):179-85. PubMed ID: 12901338
[TBL] [Abstract][Full Text] [Related]
18. Myelodysplastic syndromes according to FAB and WHO classification. Single center experience.
Haus O; Kotlarek-Haus S; Potoczek S; Czarnecka M; Duszenko E; Makowska I; Mirowska N; Kuliczkowski K
Neoplasma; 2006; 53(2):136-43. PubMed ID: 16575469
[TBL] [Abstract][Full Text] [Related]
19. [Contemporary possibilities of prognosis in myelodysplastic syndromes].
Goździk J; Lewandowski K; Hansz J
Acta Haematol Pol; 1995; 26(2):129-38. PubMed ID: 7653217
[TBL] [Abstract][Full Text] [Related]
20. The WHO classification of the myelodysplastic syndromes.
Bain B
Exp Oncol; 2004 Sep; 26(3):166-9. PubMed ID: 15494682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
